6 Present Pot Stocks To Keep An Eye On

Amid investor’s concerns about medical marijuana recalls, Aurora Cannabis stated that “the cannabis industry’s most comprehensive product testing disclosure process.”

In other investment happenings, Cronos Group announced they were re-investing in Canadian Licensed Producer, Whistler Medical Marijuana. Cronos has a 21.5% stake, and has put more money ahead of expansion plans in order to halt stake dilution.

In U.S-related marijuana stocks, we’re keeping an eye on shares of Blue Line Protection Group after they announced a nearly 300% increase in cash processing services. For those that aren’t privy with Blue Line Protection, they’re a “leading security, transportation and risk mitigation solutions provider for financial institutions servicing the legal cannabis industry.”

Also, we’ll be monitoring shares of Surna Inc., after their announcement yesterday about the closing of a financing round. Two Surna insiders announced yesterday that was selling and, giving mixed signals —in the process.

Yesterday evening, 22nd Century Group filed their 10-K annual SEC report, and scheduled a conference call to discuss results with shares of 22nd Century Group (NYSE:XXII) are flat on the day so far, but we’ll be sure to see some action as Wall Street digs into the 10-K. We anticipate further action in shares of XXII during and after the conference call that is scheduled.

In the Australian Marijuana Stocks, Zelda Therapeutics are on our radar. Shares of Zelda Therapeutics are presently down , as this volatility plays itself out.

GSN Disclaimer: Investing in stocks is highly speculative. The publishers of growthstocknetwork.com aren’t registered as Investment Advisors or Broker-Dealers in virtually any jurisdiction whatsoever. Investors should seek financial advice concerning the appropriateness of investing in almost any securities.

Leave a Reply

Your email address will not be published. Required fields are marked *